Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine
- PMID: 1221431
- DOI: 10.1159/000136942
Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine
Abstract
Disulfiram inhibited antipyrine metabolism reproducibly in three experiments utilizing three different groups of normal human volunteers. In these experiments disulfiram in a dose of 3.5 mg/kg body weight was given orally twice daily for 4 consecutive days and in two subsequent experiments for 10 consecutive days. In each experiment the mean antipyrine half-life was prolonged and the mean metabolic clearance rate of antipyrine was shortened by disulfiram. Large interindividual variations occurred; one volunteer with a very short initial plasma antipyrine half-life shortened, rather than prolonged, his antipyrine half-life after 10 days of disulfiram. In the first 10-day study the apparent volume of distribution of antipyrine was significantly increased in each volunteer after disulfiram administration, whereas in the second 10-day study, disulfiram failed to alter this value. Another anomalous result concerned attempts to determine whether a correlation existed between the initial antipyrine half-life and the percent change in this value produced by disulfiram administration. A significant correlation occurred in the initial 10-day study (4 = 0.71, p less than 0.05), whereas neither in the second 10-day study (r = 0.20, p greater than 0.05) nor in the 4-day study (r = 0.57, p greater than 0.05) was a significant correlation observed. Each of the three studies revealed no significant correlation between the initial metabolic clearance rate of antipyrine and the percent change in this value produced by disulfiram administration.
Similar articles
-
Inhibition of antipyrine elimination by disulfiram and cimetidine: the effect of concomitant administration.Br J Clin Pharmacol. 1986 Jan;21(1):75-7. doi: 10.1111/j.1365-2125.1986.tb02825.x. Br J Clin Pharmacol. 1986. PMID: 3947507 Free PMC article.
-
Quinine-induced alterations in drug disposition.Clin Pharmacol Ther. 1975 Dec;18(6):670-9. doi: 10.1002/cpt1975186670. Clin Pharmacol Ther. 1975. PMID: 1204275
-
Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.Eur J Clin Pharmacol. 1982;21(5):433-41. doi: 10.1007/BF00542332. Eur J Clin Pharmacol. 1982. PMID: 7075648
-
Unaltered metabolism of antipyrine and tolbutamide in fasting man.Clin Pharmacol Ther. 1975 Jun;17(6):650-6. doi: 10.1002/cpt1975176650. Clin Pharmacol Ther. 1975. PMID: 1139856
-
Factors influencing antipyrine elimination.Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x. Br J Clin Pharmacol. 1977. PMID: 332216 Free PMC article. Review. No abstract available.
Cited by
-
Inhibition of antipyrine elimination by disulfiram and cimetidine: the effect of concomitant administration.Br J Clin Pharmacol. 1986 Jan;21(1):75-7. doi: 10.1111/j.1365-2125.1986.tb02825.x. Br J Clin Pharmacol. 1986. PMID: 3947507 Free PMC article.
-
Assessment of methods to identify sources of interindividual pharmacokinetic variations.Clin Pharmacokinet. 1983 Sep-Oct;8(5):378-409. doi: 10.2165/00003088-198308050-00002. Clin Pharmacokinet. 1983. PMID: 6194927 Review.
-
Genetic and environmental factors affecting host response to drugs and other chemical compounds in our environment.Environ Health Perspect. 1977 Oct;20:159-82. doi: 10.1289/ehp.7720159. Environ Health Perspect. 1977. PMID: 598349 Free PMC article.
-
Assessment of the drug metabolism capacity of the liver.Br J Clin Pharmacol. 1982 Nov;14(5):631-51. doi: 10.1111/j.1365-2125.1982.tb04950.x. Br J Clin Pharmacol. 1982. PMID: 6128018 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources